Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Feeding Intolerant

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1
Completed1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT01917084Not ApplicableCompletedPrimary

Training in Exercise Activities and Motion for Growth

NCT02995577UnknownPrimary

Biomarkers for Feeding Intolerance in Infants With Complex Congenital Heart Defects Undergoing Single Ventricle Staged Palliation

NCT00156455Withdrawn

Sleep Disordered Breathing in Children With Single Ventricle Physiology

Showing all 3 trials

Research Network

Common Treatments

  • Feeding Intolerant1
  • Necrotizing Enterocolitis1
  • Passive Range Of Motion Rom Exercise1
  • Feeding Tolerant1

Active Sponsors

  • University of Rochester1
  • Carelon Research1
  • National Heart, Lung, and Blood Institute (NHLBI)1
  • The University of Texas Health Science Center, Houston1

Top Investigators

Related Conditions

  • Obstructive Sleep Apnea Syndrome1
  • Hypoplastic Left Heart Syndrome1

Activity Timeline